{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:40:54Z","timestamp":1756572054215},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:00:00Z","timestamp":1458086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00428-016-1920-2","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T20:05:47Z","timestamp":1458331547000},"page":"623-630","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma"],"prefix":"10.1007","volume":"468","author":[{"given":"Pekka","family":"Peroja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsi-Maria","family":"Haapasaari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Mannisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Miinalainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petri","family":"Koivunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Lepp\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marja-Liisa","family":"Karjalainen-Lindsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milla Elvi Linnea","family":"Kuusisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taina","family":"Turpeenniemi-Hujanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Outi","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peeter","family":"Karihtala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,16]]},"reference":[{"key":"1920_CR1","author":"AK Nooka","year":"2013","unstructured":"Nooka AK, Nabhan C, Zhou X, Taylor MD, Byrtek M, Miller TP, Friedberg JW, Zelenetz AD, Link BK, Cerhan JR, Dillon H, Sinha R, Shenoy PJ, Levy D, Dawson K, Hirata JH, Flowers CR (2013) Examination of the Follicular Lymphoma International Prognostic Index (FLIPI) in the National LymphoCare Study (NLCS): a prospective US patient cohort treated predominantly in community practices. Ann Oncol. doi: 10.1093\/annonc\/mds429","journal-title":"Ann Oncol"},{"key":"1920_CR2","author":"E Yamamoto","year":"2013","unstructured":"Yamamoto E, Tomita N, Sakata S, Tsuyama N, Takeuchi K, Nakajima Y, Miyashita K, Tachibana T, Takasaki H, Tanaka M, Hashimoto C, Koharazawa H, Fujimaki K, Taguchi J, Harano H, Motomura S, Ishigatsubo Y (2013) MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy. Cancer Sci. doi: 10.1111\/cas.12288","journal-title":"Cancer Sci"},{"key":"1920_CR3","author":"B Wood","year":"2013","unstructured":"Wood B, Sikdar S, Choi SJ, Virk S, Alhejaily A, Baetz T, LeBrun DP (2013) Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease. Leuk Lymphoma. doi: 10.3109\/10428194.2012.742522","journal-title":"Leuk Lymphoma"},{"key":"1920_CR4","author":"YJ Li","year":"2012","unstructured":"Li YJ, Jiang WQ, Rao HL, Huang JJ, Xia Y, Huang HQ, Lin TY, Xia ZJ, Li S, Li ZM (2012) Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes. PLoS ONE. doi: 10.1371\/journal.pone.0050936","journal-title":"PLoS ONE"},{"key":"1920_CR5","author":"Y Collins","year":"2012","unstructured":"Collins Y, Chouchani ET, James AM, Menger KE, Cocheme HM, Murphy MP (2012) Mitochondrial redox signalling at a glance. J Cell Sci. doi: 10.1242\/jcs.098475","journal-title":"J Cell Sci"},{"key":"1920_CR6","author":"SG Rhee","year":"2012","unstructured":"Rhee SG, Woo HA, Kil IS, Bae SH (2012) Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem. doi: 10.1074\/jbc.R111.283432","journal-title":"J Biol Chem"},{"key":"1920_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.1042","volume":"196","author":"VL Kinnula","year":"2002","unstructured":"Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y (2002) Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 196:316\u2013323","journal-title":"J Pathol"},{"key":"1920_CR8","author":"P Ren","year":"2013","unstructured":"Ren P, Ye H, Dai L, Liu M, Liu X, Chai Y, Shao Q, Li Y, Lei N, Peng B, Yao W, Zhang J (2013) Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma. Oncol Rep. doi: 10.3892\/or. 2013.2714","journal-title":"Oncol Rep"},{"issue":"1\u20132","key":"1920_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11010-013-1891-4","volume":"387","author":"W Lu","year":"2014","unstructured":"Lu W, Fu Z, Wang H, Feng J, Wei J, Guo J (2014) Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells\u2019 survival by protecting cells from oxidative stress. Mol Cell Biochem 387(1\u20132):261\u2013270","journal-title":"Mol Cell Biochem"},{"key":"1920_CR10","author":"AP Demasi","year":"2013","unstructured":"Demasi AP, Martinez EF, Napimoga MH, Freitas LL, Vassallo J, Duarte AS, Soares AB, Araujo NS, Araujo VC (2013) Expression of peroxiredoxins I and IV in multiple myeloma: association with immunoglobulin accumulation. Virchows Arch. doi: 10.1007\/s00428-013-1433-1","journal-title":"Virchows Arch"},{"key":"1920_CR11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/his.12389","volume":"65","author":"H Bur","year":"2014","unstructured":"Bur H, Haapasaari KM, Turpeenniemi-Hujanen T, Kuittinen O, Auvinen P, Marin K, Koivunen P, Sormunen R, Soini Y, Karihtala P (2014) Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas. Histopathology 65:319\u2013327","journal-title":"Histopathology"},{"key":"1920_CR12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jclinpath-2014-202771","volume":"68","author":"ME Kuusisto","year":"2015","unstructured":"Kuusisto ME, Haapasaari KM, Turpeenniemi-Hujanen T, Jantunen E, Soini Y, Peroja P, Bloigu R, Karihtala P, Kuittinen O (2015) High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of international prognostic index. J Clin Pathol 68:552\u2013556","journal-title":"J Clin Pathol"},{"key":"1920_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrc.2004.02.022","volume":"316","author":"M Murata","year":"2004","unstructured":"Murata M, Kawanishi S (2004) Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem Biophys Res Commun 316:123\u2013128","journal-title":"Biochem Biophys Res Commun"},{"key":"1920_CR14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2162-3619-1-2","volume":"1","author":"P Peroja","year":"2012","unstructured":"Peroja P, Pasanen AK, Haapasaari KM, Jantunen E, Soini Y, Turpeenniemi-Hujanen T, Bloigu R, Lilja L, Kuittinen O, Karihtala P (2012) Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma. Exp Hematol Oncol 1:2\u20133619-1-2","journal-title":"Exp Hematol Oncol"},{"key":"1920_CR15","author":"AK Pasanen","year":"2012","unstructured":"Pasanen AK, Kuitunen H, Haapasaari KM, Karihtala P, Kyllonen H, Soini Y, Turpeenniemi-Hujanen T, Kuittinen O (2012) Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas. Leuk Lymphoma. doi: 10.3109\/10428194.2011.624226","journal-title":"Leuk Lymphoma"},{"key":"1920_CR16","first-page":"87","volume":"38","author":"JW Slot","year":"1985","unstructured":"Slot JW, Geuze HJ (1985) A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol 38:87\u201393","journal-title":"Eur J Cell Biol"},{"key":"1920_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mrfmmm.2012.04.004","volume":"735","author":"V Rani","year":"2012","unstructured":"Rani V, Neumann CA, Shao C, Tischfield JA (2012) Prdx1 deficiency in mice promotes tissue specific loss of heterozygosity mediated by deficiency in DNA repair and increased oxidative stress. Mutat Res 735:39\u201345","journal-title":"Mutat Res"},{"key":"1920_CR18","author":"J Cao","year":"2009","unstructured":"Cao J, Schulte J, Knight A, Leslie NR, Zagozdzon A, Bronson R, Manevich Y, Beeson C, Neumann CA (2009) Prdx1 inhibits tumorigenesis via regulating PTEN\/AKT activity. EMBO J. doi: 10.1038\/emboj.2009.101","journal-title":"EMBO J"},{"key":"1920_CR19","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1016\/j.febslet.2005.07.049","volume":"579","author":"YH Han","year":"2005","unstructured":"Han YH, Kim HS, Kim JM, Kim SK, Yu DY, Moon EY (2005) Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. FEBS Lett 579:4897\u20134902","journal-title":"FEBS Lett"},{"key":"1920_CR20","author":"D Kubota","year":"2013","unstructured":"Kubota D, Mukaihara K, Yoshida A, Tsuda H, Kawai A, Kondo T (2013) Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma. J Proteome. doi: 10.1016\/j.jprot.2013.07.022","journal-title":"J Proteome"},{"issue":"11","key":"1920_CR21","first-page":"4821","volume":"33","author":"S Suenaga","year":"2013","unstructured":"Suenaga S, Kuramitsu Y, Wang Y, Baron B, Kitagawa T, Akada J, Tokuda K, Kaino S, Maehara S, Maehara Y, Sakaida I, Nakamura K (2013) Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells. Anticancer Res 33(11):4821\u20134826","journal-title":"Anticancer Res"},{"key":"1920_CR22","author":"QK Sun","year":"2014","unstructured":"Sun QK, Zhu JY, Wang W, Lv Y, Zhou HC, Yu JH, Xu GL, Ma JL, Zhong W, Jia WD (2014) Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. Med Oncol. doi: 10.1007\/s12032-013-0786-2","journal-title":"Med Oncol"},{"issue":"6","key":"1920_CR23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10517-012-1849-7","volume":"153","author":"EV Kalinina","year":"2012","unstructured":"Kalinina EV, Berezov TT, Shtil\u2019 AA, Chernov NN, Glazunova VA, Novichkova MD, Nurmuradov NK (2012) Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation. Bull Exp Biol Med 153(6):879\u2013882","journal-title":"Bull Exp Biol Med"},{"key":"1920_CR24","author":"T He","year":"2013","unstructured":"He T, Banach-Latapy A, Vernis L, Dardalhon M, Chanet R, Huang ME (2013) Peroxiredoxin 1 knockdown potentiates beta-lapachone cytotoxicity through modulation of reactive oxygen species and mitogen-activated protein kinase signals. Carcinogenesis. doi: 10.1093\/carcin\/bgs389","journal-title":"Carcinogenesis"},{"key":"1920_CR25","author":"L Jing","year":"2011","unstructured":"Jing L, Wu Y, Wu J, Zhao J, Zuo D, Peng S (2011) Peroxiredoxins are involved in metallothionein protection from doxorubicin cardiotoxicity. Eur J Pharmacol. doi: 10.1016\/j.ejphar.2011.03.031","journal-title":"Eur J Pharmacol"},{"key":"1920_CR26","author":"A Nicolussi","year":"2014","unstructured":"Nicolussi A, D\u2019Inzeo S, Mincione G, Buffone A, Di Marcantonio MC, Cotellese R, Cichella A, Capalbo C, Di Gioia C, Nardi F, Giannini G, Coppa A (2014) PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms. Int J Oncol. doi: 10.3892\/ijo.2013.2208","journal-title":"Int J Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-1920-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-016-1920-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-1920-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:22:31Z","timestamp":1559078551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-016-1920-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,16]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1920"],"URL":"https:\/\/doi.org\/10.1007\/s00428-016-1920-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,16]]}}}